Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 12:46 pm Purchase | 2025-09-30 | 13G | Femasys Inc. FEMY | Dauntless Investment Group, LLC | 4,395,996 9.900% | 2,966,151 (+207.45%) | Filing History |
| 2025-09-04 9:35 pm Purchase | 2025-09-04 | 13G | Femasys Inc. FEMY | Alumni Capital LP | 4,773,579 9.990% | 4,773,579 (New Position) | Filing History |
| 2025-08-05 3:28 pm Purchase | 2025-06-30 | 13G | Femasys Inc. FEMY | Chernett Jorey | 3,034,335 9.300% | 1,410,022 (+86.81%) | Filing History |
| 2025-02-26 8:10 pm Purchase | 2025-02-19 | 13G | Femasys Inc. FEMY | Chernett Jorey | 1,624,313 6.200% | 1,624,313 (New Position) | Filing History |
| 2025-02-26 1:46 pm Purchase | 2025-02-18 | 13G | Femasys Inc. FEMY | Dauntless Investment Group, LLC | 1,429,845 5.400% | 1,429,845 (New Position) | Filing History |
| 2023-11-22 4:00 pm Purchase | 2023-11-14 | 13D | Femasys Inc. FEMY | PharmaCyte Biotech Inc. PMCB | 12,711,864 37.000% | 12,711,864 (New Position) | Filing History |